The FDA pulled Zantac and its generic versions off the market after a cancer-causing substance called NDMA was found in samples of the drug. Read this story
The FDA pulled Zantac and its generic versions off the market after a cancer-causing substance called NDMA was found in samples of the drug. Read this story
More from dailym.ai | dailymail health Pfizer FDA Cancer